Stock Snapshot from
Johnson & JohnsonAdd to My Watchlist
JNJ:USNew YorkIndustry: Medical-Drugs
- 88.09Last
- 0.64 0.73%Today's Change
- 87.45Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | 5.180 |
| EPS: Year Est. 12/13 ttm | 5.412 |
| EPS: Quarterly Actual 3/13 | 1.44 |
| EPS: Quarterly Est. 6/13 | 1.39 |
| Price/Earnings ttm | 17.01 |
| Relative Price/Earnings | 1.042 |
| Earnings Growth Rate | 11.30 |
Company Description
| Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. | |
| Revenue | $67 billion |
| Net Income | $11 billion |
| Total Assets | $121 billion |
| Employees | 127,600 |
| Web Site | www.jnj.com |
Latest Headlines
- Johnson & Johnson Ending Metal-on-Metal Hip Implant Sales
- J&J Wins Expanded Approval of Simponi to Treat Bowel Disease
- Bayer, Algeta Win Approval for Prostate Cancer Medication
- Primecap Rides Health Care to No. 1 Growth Fund: Riskless Return
- MorphoSys Chief Moroney Says Company Not Interested in Selling
- Surgery for Vaginal Bulge Fails in One in Four Women, Study Says
- Boston Scientific’s Mahoney Says Watchman Critical to Growth
- Obesity Surgery in India Spurs J&J Stomach-Staple Sales: Health
- J&J Says It Recalls Some Children’s Tylenol in South Korea
- MorphoSys CFO Says Company Still Aims for Arthritis Drug Deal
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.